Culture

Breathing rate predicts therapeutic benefits for heart patients

Conditions causing arrhythmia are among the most common cardiac conditions. A study headed by Prof. Georg Schmidt of the Technical University of Munich (TUM) has demonstrated for the first time that the nocturnal respiratory rate can help with an important prediction: It is an indicator of whether a defibrillator will help to extend the life of patients with arrhythmia.

Sudden cardiac death is one of the leading causes of mortality in western industrialized countries. It can be prevented by an implantable cardioverter defibrillator (ICD). This automatically detects life-threatening heart rhythms and emits electrical signals to stop them. The guidelines recommend the implantation of ICDs in patients with a significantly weakened pump function of the left ventricle. According to the German Heart Surgery Report, more than 42,000 defibrillators were implanted in Germany in 2018.

However, the effectiveness of implanting ICDs is sometimes questionable. The latest Heart Surgery Report by the German Heart Foundation also notes that the benefits of defibrillator therapy are not as clear-cut as previously believed. Moreover, they are often offset by relatively common complications arising both during and after the implantation procedure.

Predictive value of the nocturnal respiratory rate

Researchers at TUM have now demonstrated that the nocturnal respiratory rate of heart patients - which has hitherto received little attention - can help to predict the success of ICD treatment. Between May 2014 and September 2018 they monitored 1,971 heart patients at 44 European heart centers. 1,363 of the patients received an ICD, while the control group was treated conservatively. The different treatment options were dictated by the varying availability of ICD therapy at the participating European centers. Consequently, the study was non-randomized. However, the resulting distortions were compensated for through sophisticated statistical analysis. The study has now been published in eClinicalMedicine, an open-access journal produced by the renowned journal The Lancet.

In both groups the scientists measured the average nocturnal respiratory rate between midnight and 6 am based on an ECG protocol. The ICD patients had a survival advantage of 31.3 percent over the control group. At the same time, a significant link was seen between a low nocturnal respiratory rate and reduced mortality: ICD patients with a rate below 18 breaths per minute had a 50 percent survival advantage as compared to the control group, while those with a higher nocturnal respiratory rate gained no survival advantage through the defibrillator.

A biosignal hitherto neglected by cardiologists

"The breathing rate has been largely ignored as a biosignal in the field of cardiology," says Prof. Georg Schmidt, the last author of the study, who heads the working group for biosignal processing at TUM's university hospital Klinikum rechts der Isar. "Our conclusions will now place a greater focus on this parameter," says Prof. Schmidt, noting that the study demonstrates the predictive value of breathing frequency for therapeutic efficacy. "Especially in borderline cases, checking the patient's breathing rate can help to decide on the right therapy."

Randomized study needed

Against this backdrop, Schmidt, who also chairs the TUM Ethics Commission, believes that it would be reasonable to aim for a randomized study versus the established guidelines. "This would involve dividing the patients observed to gain no advantage from the ICD in our study into two groups, with one having an ICD implanted and the other receiving conservative treatment. If a randomized study of this kind reveals that heart patients with a higher nocturnal breathing rate do not benefit from the ICD implant, they could be spared this invasive treatment in the future."

Credit: 
Technical University of Munich (TUM)

Researchers explore why some MS patients experience seizures

image: Image shows astrocytes (green) in MS hippocampus.

Image: 
Tiwari-Woodruff lab, UC Riverside.

RIVERSIDE, Calif. -- A research team at the University of California, Riverside School of Medicine has identified a pathway involving astrocytes, a class of central nervous system support cells, that could shed light on why seizures happen in a subset of multiple sclerosis, or MS, patients.

Study results, available in ASN Neuro, improve scientific understanding of how seizures arise in MS and could provide the foundation for better therapies to manage treatment-resistant seizures in MS and other brain diseases.

Characterized by progressive episodic decline in neurological function, MS affects more than 900,000 people in the United States. This autoimmune disease damages the fatty sheath -- myelin -- that protects nerve fibers, which hinders the speed of signals in the central nervous system. While not classically considered a defining symptom of the disease, seizures occur three-times more often in MS patients than healthy individuals and may portend a flare-up of symptoms. MS patients that experience seizures also have a decreased quality of life and higher mortality rate. The mechanisms that cause seizures in MS patients remains poorly understood.

"During a seizure, there is a dysfunction between inhibition and excitation and a bunch of neurons fire together without control," said Seema Tiwari-Woodruff, a professor of biomedical sciences and senior author on the paper.

Neurons are cells in the central nervous system that transmit information between the body or other neurons to allow us to move, feel, and think. Astrocytes provide the fastidiously maintained environment that the neurons need to perform by controlling the molecular signals present in the brain. Seizures can occur when astrocytes are unable to keep up with this task.

Tiwari-Woodruff and her colleagues examined postmortem brain tissue obtained from MS patients who experienced seizures (7 samples) and MS patients that did not (21 samples). The team found that astrocytes in the hippocampal samples taken from MS patients with seizure showed signs of being less able to regulate the kinds of signals likely to cause a seizure. They observed reduced synaptic glutamate (EEAT2), impaired water and potassium ion buffering (AQP4) and altered gap junction coupling between astrocytes (CX43) in MS patients with seizures. In addition, connections between astrocytes were altered in MS patients with seizures, a finding also noted in epileptic brains but never observed before in MS patients.

"The most exciting aspect of the study was discovering that astrocytes in the brains of MS patients with seizures looked a lot like astrocytes in epileptic brains," said Andrew S. Lapato, a postdoctoral fellow at the University of Colorado, Anschutz Medical Campus who as first author conducted the work as part of his graduate studies in Tiwari-Woodruff's lab. "Researchers might be able to enhance the support roles of astrocytes or compensate for their dysfunction to prevent or treat seizures in MS patients."

EAAT2 is the most widely distributed glutamate transporter in mammalian brains. A reduction in EAAT2 allows the neurons to fire more frequently, resulting in increased seizure activity. The reduction in this transporter has been observed in both patients with MS and temporal lobe epilepsy.

AQP4 maintains the extracellular space volume that allows for ion movement across the connective tissue of the nervous system. A reduction in AQP4 allows the concentration of extracellular potassium ions to increase, which may depolarize neurons and lead to hyperexcitability and protracted stimulation-evoked seizures. The researchers found these results are analogous to epilepsy, suggesting a similar process in MS patients with seizures.

Previous studies found CX43, the major connexin isoform expressed by astrocytes, is altered in response to inflammation or demyelination. Increased CX43 expression is also common in patients with epilepsy. While this study was unable to draw a more definitive link between CX43 and seizure activity, it opens another pathway to explore in future studies.

For this study, the team obtained 28 brain tissue samples from the National Institute of Health NeuroBioBank/Human Brain & Spinal Fluid Resource Center brain bank at the University of California, Los Angeles. The samples in the study were 57% female and 43% male patients. The samples for MS with seizures represent male and female patients almost equally.

"One of the treasures of having post-mortem brain tissues for our study is that we can use them to see how expressed proteins differ among MS patients," Tiwari-Woodruff said. "If we don't know what the disease looks like, then we don't know what we can do to treat it."

Credit: 
University of California - Riverside

Hormone metabolites found in poop give researchers new insight into whale stress

image: Oregon State University researchers are studying gray whales along the Oregon Coast. Images and data collected under NOAA/NMFS permit #21678.

Image: 
Oregon State University Marine Mammal Institute

NEWPORT, Ore. - Poop samples are an effective, non-invasive tool for monitoring gray whale reproduction, stress and other physiological responses, a new study from Oregon State University shows.

Researchers from OSU's Geospatial Ecology of Marine Megafauna Laboratory collected 158 fecal, commonly known as poop, samples from Eastern North Pacific gray whales off the coast of Oregon between 2016 and 2018 and used the samples to assess endocrine levels and establish hormone baselines for stress and reproduction in the animals.

The study is believed to be the first to use fecal samples as an endocrine assessment tool in Eastern North Pacific gray whales. Fecal samples can provide a wide range of important information about whale health in a noninvasive way, said Leigh Torres, an associate professor in OSU's Marine Mammal Institute and director of the GEMM Lab.

"Understanding whale physiology is really important to evaluate how human, activities impact whales," Torres said. "But it is really, really hard to study whale physiology. You can't observe most physiological responses. And you can't just ask a whale: Are you stressed out? So we have to get creative."

The findings were published this month in the journal Conservation Physiology. The paper's lead author is Leila Soledade Lemos, who recently completed her doctorate in Oregon State's Department of Fisheries and Wildlife and worked with Torres in the GEMM Lab. Lemos is now a postdoctoral associate at Florida International University.

Most gray whales migrate from breeding grounds in Mexico to feeding grounds in the Bering and Chukchi seas between Alaska and Russia, where they spend the summer. Torres and her team study a distinct population of gray whales known as the Pacific Coast Feeding Group, which spend the summer months feeding in coastal waters of Oregon, as well as northern California, Washington and southern Canada.

Torres and her research team have been observing and conducting annual "health check-ups" on this population since 2016. When they spot a defecating whale from a boat or via a drone, they follow in the animal's wake and use nets to capture samples. The drones are also used to capture images of the whales, allowing researchers to monitor the animals' body condition and behavior.

Researchers used the collected fecal samples to analyze four hormone metabolites: two reproductive hormones; a stress hormone; and thyroid, which can indicate nutrition-related stress.

With this data, the researchers were able to see how hormones fluctuated with a whale's age and sex and establish baseline hormone levels for different cycles of a whale's life, including during pregnancy.

"This was a first step to understanding how hormones vary through a whale's life cycle and in times of stress," Lemos said. "It helps us establish baselines and ranges of hormone levels."

The researchers also were able to document a stressful event in a specific whale. They collected a fecal sample from a whale within 24 hours of a documented injury from a propeller or vessel strike. The fecal sample collected after the injury showed a spike in stress hormone levels, almost three times higher than this whale's stress levels on previous days without the injury.

The researchers also captured a fecal sample from a mature male who was engaged in competitive reproductive behavior with another male whale. That whale's testosterone level was very high and may reflect the typical hormone levels of adult breeding males. The researchers' ability to connect fecal samples to specific individual whales adds important context to the data to help understand what drives hormone variation, Torres said.

Researchers have continued to collect fecal samples over the last two summers and will continue to analyze hormones as part of their broader work on whale health.

The researchers' ultimate goal is to understand how variations in human-generated ocean noise impacts whale health, Torres said. Analysis of fecal samples is emerging as an important new tool for understanding how different stressors impact whale physiology. They also hope to use the endocrine information to better understand the role of nutrition and changes in diet on overall whale health.

"Our ability to link hormone variation to an individual's condition is really a significant advance for the study of whale physiology," Torres said. "All of our future work on impacts of disturbance events will build on this foundation. It's super exciting to be able to use these tools to think about whale life in a holistic way."

Credit: 
Oregon State University

Virtual kidney transplant evaluation allows patients to be evaluated from home

video: Maintaining equity and access: Successful implementation of a virtual kidney transplant evaluation.

Image: 
American College of Surgeons

CHICAGO (December 21, 2020): A virtual telehealth platform is allowing the surgery program at the Medical University of South Carolina (MUSC) to evaluate and wait-list patients for kidney transplantation despite reductions in direct, in-person health care visits brought about by the Coronavirus Disease 2019 (COVID-19) pandemic. Between April and September, surgical teams have been able to perform more transplant evaluations and add the same number of patients to the wait list as they did in the same period last year, according researchers whose study was selected for the 2020 Southern Surgical Association Program and published online as an "article in press" by the Journal of the American College of Surgeons in advance of print.

"Because of the platform, we can give continuous access to patients in the kidney transplantation program even in the midst of a pandemic that has restricted access to the hospital. We can provide access to kidney transplantation even for patients who have difficulty getting to the transplant center because of where they live or who have difficulties due to their socioeconomic status," said Vinayak S. Rohan, MD, FACS, an assistant professor of surgery and lead study author. Patients in the virtual telehealth program lived, on average, 130 miles from the transplant center, and 65 percent were African American.

Before being considered for kidney transplantation, patients with end-stage renal disease must undergo a comprehensive evaluation that includes a medical and surgical history, physical and psychosocial exam, and blood testing for compatibility with an eventual donated organ.

Depending on a patient's condition, other testing may be ordered, including blood testing for the overall function of the heart, kidneys, liver, thyroid, and immune system, as well as targeted studies of the lungs and heart, cancer screening, colonoscopy, gynecologic or prostate examination, and dental workup to be sure there is no sign of infection or gum disease that could affect the immune system.1

This evaluation is routinely done in one or more in-person visits to the transplantation center or to primary or other physicians' offices. However, the onset of COVID-19 severely limited patient access to non-urgent care and closed ambulatory clinics that conduct kidney transplant evaluation.

An operational team from MUSC's division of transplant surgery quickly moved to reduce the need for in-person visits by implementing a virtual kidney transplant evaluation. The team included transplant surgeons, nephrologists, advanced practice practitioners, social workers, and other members of the surgical quality improvement program.

The research team stratified patients who had recently been referred by their doctors or dialysis units for possible transplantation and were in the process of pre-transplant review by providers and insurance carriers. After an initial review of their medical records, patients were stratified into one of three groups.

The first, or "red," group included patients whose age or medical condition made it unlikely they would end up being candidates for transplantation and therefore require a full presurgical evaluation. Patients in this group were over age 70 and had a history of stroke, significant cardiac or peripheral vascular disease, or poor functional status.

The second, or "green," group included patients who were likely to be candidates for transplantation and placed on the wait list for a donated organ. Patients in this group were under 45 years of age and had no history of diabetes.

The third group, or "yellow," group included "fast track" patients as well as all other patients. "Fast track" patients were on the wait list at another transplantation center and required minimum further workup.

Patients were scheduled and evaluated by the virtual platform based on this stratification. "Fast-track" patients were expedited through the virtual evaluation. These patients were followed by individuals in the red and green groups.

After an initial call to determine if a patient or a family member could use a smart phone or tablet and verify insurance, the patient was scheduled for check-in, a link to the doxy.me virtual platform was sent, and the telehealth visit was completed. The doxy.me virtual platform was chosen because it is easy to use, complies with HIPAA privacy, and does not require additional software to complete the visit.

Between April and September, 176 transplantations were performed. Of the 1,148 patients who were referred for transplantation, 930 underwent virtual evaluation and 282 were placed on the wait list. In the same period in 2019, 177 transplantations were performed. Of 1,639 patients referred, 880 were evaluated and 308 were wait-listed.

Dr. Rohan believes this type of platform can be used by any medical specialty even after the pandemic. "However, we need new regulations to achieve this goal," he pointed out.

Provisions in the national COVID-19 aid and relief legislation, the CARES Act, made the shift to the virtual evaluation platform possible by expanding Medicare coverage for telehealth during the pandemic.2,3

"We need to continue this practice in the future, even after the CARES Act expires, and expand care across state lines so that patients can continue having access to medical care across all specialties," he said.

Credit: 
American College of Surgeons

Do I know you? Researchers evaluate how masks disrupt facial perception

image: The identification of people wearing masks has often presented a unique challenge during the pandemic. A new study by researchers from Ben-Gurion University of the Negev (BGU) in Israel and York University in Canada reveals the impact of this predicament and its potentially significant repercussions.

Image: 
Chicago Face Database (Ma et al., 2015)

BEER-SHEVA, Israel...December 21, 2020 - The identification of people wearing masks has often presented a unique challenge during the pandemic. A new study by researchers from Ben-Gurion University of the Negev (BGU) in Israel and York University in Canada reveals the impact of this predicament and its potentially significant repercussions.

The findings were just published in the journal Scientific Reports.

"For those of you who don't always recognize a friend or acquaintance wearing a mask, you are not alone," according to the researchers Prof. Tzvi Ganel, head of the Laboratory for Visual Perception and Action at the BGU Department of Psychology, and Prof. Erez Freud, who earned his Ph.D. at BGU and is now a faculty member at York University in Toronto, Ontario.

"Faces are among the most informative and significant visual stimuli in human perception and play a unique role in communicative, social daily interactions," the researchers note. "The unprecedented effort to minimize COVID-19 transmission has created a new dimension in facial recognition due to mask wearing."

To examine the effects of wearing masks, Prof. Ganel and Prof. Freud used a modified version of the Cambridge Face Memory Test, the standard for assessing facial perception, which included masked and unmasked faces. The study was conducted online with a large group of nearly 500 people.

The researchers found that the success rate of identifying someone wearing a mask was reduced by 15%. “This could lead to many errors in correctly recognizing people we know, or alternatively, accidently recognizing faces of unfamiliar people as people we know,” says Prof. Galia Avidan who is a member of the BGU Department of Psychology and the Department of Cognitive and Brain Sciences, and an expert on facial recognition and perception. "Face masks could be even more challenging to people whose face recognition skills are not ideal to begin with and cause greater impairment."

The research team also found that masks specifically interfered with extracting a holistic impression of faces and led to feature-by-feature processing which is a less accurate and more time-consuming strategy.

"Instead of looking at the entire face, we're now forced to look at eyes, nose, cheeks, and other visible elements separately to construct an entire facial face percept - which we used to do instantly," the researchers say.

These changes in performance, along with the alteration along the processing style of faces, could have significant effects on activities of daily living, including social interactions, as well as other situations involving personal interactions, such as education.

"Given that mask wearing has rapidly become an important norm in countries around the globe, future research should explore the social and psychological implications of wearing masks on human behavior," Ganel says. "The magnitude of the effect of masks that we report in the current study is probably an underestimation of the actual degree in performance dropdown for masked faces."

Credit: 
American Associates, Ben-Gurion University of the Negev

Crikey! Massive prehistoric croc emerges from South East Queensland

image: The 'swamp king' was one intimidating croc.

Image: 
The University of Queensland

A prehistoric croc measuring more than five metres long - dubbed the 'swamp king' - ruled south eastern Queensland waterways only a few million years ago.

University of Queensland researchers identified the new species of prehistoric croc - which they named Paludirex vincenti - from fossils first unearthed in the 1980s.

UQ PhD candidate Jorgo Ristevski, from UQ's School of Biological Sciences, said they named the species after Geoff Vincent who discovered the giant fossilised skull near the town of Chinchilla.

"In Latin, 'Paludirex' means 'swamp king', and 'vincenti' honours the late Mr Vincent," he said.

"For several years the fossilised skull was on display in the Queensland Museum, before it was donated to the Chinchilla Museum in 2011.

"The 'swamp king' was one intimidating croc.

"Its fossilised skull measures around 65 centimetres, so we estimate Paludirex vincenti was at least five metres long.

"The largest crocodylian today is the Indo-Pacific crocodile, Crocodylus porosus, which grows to about the same size.

"But Paludirex had a broader, more heavy-set skull so it would've resembled an Indo-Pacific crocodile on steroids."

Paludirex was one of the top predators in Australia a few million years ago, capable of preying on giant prehistoric marsupials.

"The waterways of the Darling Downs would once have been a very dangerous place because of it," Mr Ristevski said.

Mr Ristevski's supervisor, Dr Steve Salisbury, said various species of prehistoric crocodylians had existed in Australia.

"Crocs have been an important component of Australia's fauna for millions of years," Dr Salisbury said.

"But the two species we have today -- Crocodylus porosus and Crocodylus johnstoni -- are only recent arrivals, and were not part of the endemic croc fauna that existed here from about 55 million years ago.

"Whether Paludirex vincenti went extinct as a result of competition with species like Crocodylus porosus is hard to say.

"The alternative is that it went extinct as the climate dried, and the river systems it once inhabited contracted - we're currently investigating both scenarios."

The research has been published in the open access journal PeerJ (DOI: 10.7717/peerj.10466).

Credit: 
University of Queensland

Anti-diarrhoea drug drives cancer cells to cell death

The research group led by Dr Sjoerd van Wijk from the Institute of Experimental Cancer Research in Paediatrics at Goethe University already two years ago found evidence indicating that the anti-diarrhoea drug loperamide could be used to induce cell death in glioblastoma cell lines. They have now deciphered its mechanism of action and, in doing so, are opening new avenues for the development of novel treatment strategies.

When cells digest themselves

In certain types of tumour cells, administration of loperamide leads to a stress response in the endoplasmic reticulum (ER), the cell organelle responsible for key steps in protein synthesis in the body. The stress in the ER triggers its degradation, followed by self-destruction of the cells. This mechanism, known as autophagy-dependent cell death occurs when cells undergo hyperactivated autophagy. Normally, autophagy regulates normal metabolic processes and breaks down and recycles the valuable parts of damaged or superfluous cell components thus ensuring the cell's survival, for example in the case of nutrient deficiency. In certain tumour cells, however, hyperactivation of autophagy destroys so much cell material that they are no longer capable of surviving.

"Our experiments with cell lines show that autophagy could support the treatment of glioblastoma brain tumours," says van Wijk. Glioblastoma is a very aggressive and lethal type of cancer in children and adults that shows only a poor response to chemotherapy. New therapeutic approaches are therefore urgently required. The research group led by van Wijk has now identified an important factor that links the ER stress response with the degradation of the ER (reticulophagy): The "Activating Transcription Factor" ATF4 is produced in increased amounts both during ER stress and under the influence of loperamide. It triggers the destruction of the ER membranes and thus of the ER.

Anti-diarrhoea drug triggers cell death in glioblastoma cells

"Conversely, if we block ATF4, far fewer cells in a tumour cell culture die after adding loperamide," says van Wijk, describing the control results. In addition, the research group was able to detect ER debris in loperamide-treated cells under the electron microscope. "ER degradation, that is, reticulophagy, visibly contributes to the demise of glioblastoma cells," says van Wijk. The team also showed that loperamide triggers only autophagy but not cell death in other cells, such as embryonic mouse fibroblasts. "Normally, loperamide, when taken as a remedy against diarrhoea, binds to particular binding sites in the intestine and is not taken up by the bowel and is therefore harmless".

Mechanism of action also applicable to other diseases

The loperamide-induced death of glioblastoma cells could help in the development of new therapeutic approaches for the treatment of this severe form of cancer. "However, our findings also open up exciting new possibilities for the treatment of other diseases where ER degradation is disrupted, such as neurological disorders or dementia as well as other types of tumour," says van Wijk. However, further studies are necessary before loperamide can actually be used in the treatment of glioblastoma or other diseases. In future studies it has to be explored, for example, how loperamide can be transported into the brain and cross the blood-brain barrier. Nanoparticles might be a feasible option. The research team in Frankfurt now wants to identify other substances that trigger reticulophagy and examine how the effect of loperamide can be increased and better understood.

Credit: 
Goethe University Frankfurt

New study: available drugs can prevent rejection and tissue injury after transplantation

image: Activation of monocytes (Kupffer cells) was determined with a pulse of carbon (arrows, black grains). A: Healthy liver with limited carbon incorporation indicates most Kupffer cells are inactive. B: Liver showing an example of extensive carbon uptake six hours after cell transplantation. C: Cell transplantation in the presence of immunosuppression with mycophenolate mofetil and tacrolimus reveals that Kupffer cells remain active. D. Cell transplantation with immunosuppressive drugs plus blocking of TNF prevents Kupffer cell activation. Original magnification, x200. Toluidine blue counterstain.

Image: 
Albert Einstein College of Medicine

Philadelphia, December 21, 2020 - Controlling inflammation after transplantation of organs, cells, or tissues is critical for graft survival; however, it can be difficult. Continuing injuries due to chronic rejection can be particularly problematic. Now, a team of researchers from Albert Einstein College of Medicine report that neutralizing the cell signaling molecule, tumor necrosis factor (TNF), can prevent cascades of injurious molecules and signals after cell transplantation in The American Journal of Pathology, published by Elsevier.

"New insights into immune inflammatory mediators indicate that rejection and tissue injury can be avoided with available drugs," explained director of the research team Sanjeev Gupta, MD, Department of Medicine and of Pathology, and Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, NY, USA. "The ability to prevent and/or control tissue injury will improve graft survival for transplantation medicine, advance use of cells and tissues for regenerative medicine, and offer insights for controlling inflammation-related tissue injury in other circumstances."

Transplanting organs from unrelated or mismatched donors into individuals triggers immunological defenses against "foreign" material. Development of immunosuppressive drugs to block lymphocyte responses has delivered success in the short term, but chronic rejection and tissue injury over long periods due to unidentified mechanisms and processes can lead to the loss of transplanted organs.

To understand the factors at work in tissue rejection, the researchers at Albert Einstein College of Medicine developed liver cell transplantation models in laboratory rats with or without immunosuppression, using drugs routinely given to humans. The state of inflammation was studied using gene expression arrays to query the activation of soluble signals associated with various cell types. The analysis was guided by recent advances in mapping gene expression differences and the networks affected during complex interactions using commercially available computer software. The software queries the scientific literature to suggest relationships and negative or positive reactions in genes.

The studies identified differences in the expression of 40-50 soluble networks. In particular, the activation of TNF, a major inflammatory mediator, and its cellular receptors is prominent, persisting over the long term.

Blocking TNF stopped the activation of most other inflammatory signals, revealing that it is a "master switch" for orchestrating cytokines, chemokines, and receptors arising from the body's innate or inbuilt systems defending against foreign material, e.g., microbes, viruses, and mismatched transplants. To further understand the role of TNF, the researchers neutralized it with the well-established drugs etanercept or thalidomide to improve cell transplant outcomes alongside conventional immunosuppression with tacrolimus and mycophenolate mofetil.

Computer mapping of gene expression showed that blocking TNF markedly decreases the recruitment and activity of inflammatory cells. Other studies provided direct evidence that blocking TNF led to superior survival and proliferation of transplanted cells, regenerating the liver far more effectively.

Lead author Fadi-Luc Jaber, PhD, Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, NY, USA, commented "The efficacy of this anti-inflammatory mechanism for liver regeneration surprised me. These mechanisms will provide further means to treat liver conditions."

"The translational potential of these findings is exciting because the additional inflammatory markers and genes offer further means for diagnosing the pathology of organ rejection in individuals. This type of inflammatory interference will decrease tissue injury, promote graft survival, and survival of transplanted cells and engineered tissues, and help advance organ regeneration," observed Dr. Gupta. "The inflammatory cascades orchestrated through TNF also hold lessons for the pathology in other less well understood conditions, such as COVID-19."

Credit: 
Elsevier

A community-level intervention reduces alcohol-related crashes

New research from the Prevention Research Center of the Pacific Institute for Research and Evaluation shows that a community-level alcohol intervention in California resulted in a 17% reduction in alcohol-involved crashes among drivers aged 15-30.

The research study assessed an intervention aimed at reducing excessive drinking and harm among teens and young adults, including driving under the influence. Twenty-four California cities were chosen at random for the study with 12 cities then randomly assigned the intervention and 12 cities assigned as controls.

Interventions included sobriety checkpoints, saturation patrols, and undercover operations to reduce service of alcohol to intoxicated bar patrons, with all interventions accompanied by high visibility to raise public awareness. The effect of these efforts translates into about 310 fewer crashes across the intervention cities.

Says lead author, Dr. Robert Saltz: "The impact of alcohol control policies, whether at the city, state, or national level, ultimately depends on local enforcement. Even though numerous strategies to reduce alcohol-impaired driving have been employed over the years, the study shows that enhanced alcohol interventions involving partnerships of community health and law enforcement agencies can further reduce alcohol-impaired driving and related consequences among young people."

Credit: 
Pacific Institute for Research and Evaluation

Protecting against atherosclerosis at the molecular level

Tsukuba, Japan - Atherosclerosis is the result of a buildup of lipids in the inner walls of blood vessels, and is a major cause of heart disease and stroke. In a new study, researchers from the University of Tsukuba discovered a novel role for cAMP responsive element-binding protein 3 like 3 (CREB3L3) in the development of atherosclerosis and identified a mechanism by which it exhibits protective effects against atherosclerosis.

Atherosclerosis is the detrimental result of long-time high blood lipid levels leading to a thickening of the inner walls of blood vessels through the formation of a so-called plaque. As a result, blood flow to the brain and heart may decrease over time, and once the plaque ruptures, platelets in the blood stream aggregate and clog the blood vessel as they try to repair the damage. While a number of proteins and mechanisms are known to play a part in the development of atherosclerosis, research is ongoing to fully understand this complex process. CREB3L3 is a transcription factor, which is a protein that binds to DNA and regulates gene expression in the liver and small intestine, and plays an important role in the hepatic triglyceride and glucose metabolism.

"Though we have known about atherosclerosis for a long time now, there is still much to learn about the molecular basis for it," corresponding author of the study Professor Hitoshi Shimano says. "The goal of our study was to understand the role CREB3L3 plays in the development of atherosclerosis and whether it lends itself to a therapeutic target against atherosclerosis."

To achieve their goal, the researchers looked into how the absence or the overexpression of CREB3L3 would affect the development of atherosclerosis. To investigate the absence of CREB3L3, the researchers generated knockout mice that were deficient in the protein in the liver or intestines, or both. To investigate the overexpression, the researchers generated a transgenic mouse overexpressing CREB3L3 in the liver. Because atherosclerosis does not naturally occur in mice, the researchers made use of a mouse line, in which the receptor of LDL cholesterol (LDLR), commonly known as "bad" cholesterol, is absent. Because LDL cholesterol circulating in the build cannot be taken up by cells, it builds up in blood vessel walls and leads to the formation of atherosclerosis. By crossing CREB3L3 mice with the LDLR mouse and feeding them with a western diet, the researchers had a system to study the role of CREB3L3 in the development of atherosclerosis.

Interestingly, the researchers found that absence of CREB3L3 in either the liver or intestines resulted in an exacerbation of high blood lipid levels and atherosclerosis formation, and more so in the mice, in which CREB3L3 was knocked out in both organs. Conversely, overexpressing the protein in the liver markedly suppressed blood cholesterol levels and atherosclerosis formation. By looking closer at the molecular mechanism by which CREB3L3 confers protective effects against atherosclerosis, the researchers found that it interacts with sterol regulatory element-binding protein (SREBP) to trap it in a cellular compartment called endoplasmic reticulum and prevent it from inducing the expression of genes important for the formation of atherosclerosis.

"These are striking results that provide a mechanism by which CREB3L3 exhibits anti-atherosclerotic effects, making it an interesting, potential novel target against atherosclerosis," Professors Shimano and Nakagawa, the first author, say.

Credit: 
University of Tsukuba

Scientists solve 'flea mystery'

image: A living flea.

Image: 
NIGPAS

With almost every aspect of their biology and anatomy adapted to their specialized parasitic lifestyle, fleas have long troubled evolutionary biologists. Their early evolution and position on the insect tree of life remained a mystery even after the first flea genomes were sequenced over the last decade.

Now, however, researchers from the Nanjing Institute of Geology and Palaeontology of the Chinese Academy of Sciences (NIGPAS) and the University of Bristol in the UK have solved this long-standing evolutionary riddle.

Their study was published in Palaeoentomology, the official publication of the International Palaeoentomological Society, on Dec. 21.

Of all the parasites in the animal kingdom, fleas hold a pre-eminent position. After all, the Black Death, caused by a flea-transmitted bacterium, was the deadliest pandemic in the recorded history of mankind.

"Despite their medical significance, the placement of fleas on the tree of life represents one of the most persistent enigmas in the evolution of insects," said Erik Tihelka, undergraduate at the University of Bristol who led the study.

Over the years, researchers have proposed many hypotheses regarding the origin of fleas, most arguing that their closest relatives lie among the flies or scorpionflies, or both.

In this study, the scientists used genome-scale sequences of fleas and all their possible close relatives, then analyzed them using new statistical methods. By employing more sophisticated algorithms to test all historically proposed hypotheses and search for new potential relationships, the team came to an unexpected conclusion - fleas are a group of highly modified, parasitic scorpionflies.

Scorpionflies are a group of small- to medium-sized flying insects distributed worldwide. The new study suggests that the small scorpionfly family Nannochoristidae, which is endemic to the southern hemisphere and whose adults probably feed on nectar, is the closest relative of all living fleas. Despite looking very unlike the flea we know today, the Nannochoristidae in fact share surprising anatomical similarities with fleas such as characteristics of the head and the sperm pump.

Why was the "flea mystery" so hard to solve?

"A close relationship between Nannochoristidae and the fleas has been proposed in several past molecular analyses but was treated as likely an error. Ancient evolutionary radiations leave behind subtle clues in organisms' genomes that can only be recovered with sophisticated models of molecular evolution. Moreover, the nannochoristids are a quite rare and little-studied group that only occurs in New Zealand, southeastern Australia, Tasmania, and Chile, so they are easy to overlook," explained Tihelka.

"The new results suggest that we may need to revise our entomology textbooks. Fleas no longer deserve the status of a separate insect order, but should actually be classified within the scorpionflies," said CAI Chenyang, associate professor at NIGPAS and expert on Mesozoic insects.

The new findings agree with fossil evidence. "We have exceptionally preserved fossil fleas from the Jurassic and Cretaceous. In particular, some Jurassic fleas from China, about 165 million years old, are truly giant and measure up to two centimeters. They may have fed on dinosaurs, but that is exceedingly difficult to tell. What is more interesting is that these ancient fleas share important characteristics with modern scorpionflies," said CAI.

"Sometime between the Permian and Jurassic, a group of scorpionflies started feeding on the blood of vertebrates. This group gave rise to fleas as we know them today," added Prof. HUANG Diying of NIGPAS.

"It is interesting," commented Mattia Giacomelli, a Ph.D. student at the University of Bristol who participated in the study. "We used to think that all blood-feeding parasitic insects basically started off by either being predators or living in close association with their vertebrate hosts, like in their nests. The case of fleas shows that blood feeding can evolve in groups that originally fed on nectar and other plant secretions. It seems that the elongate mouthparts that are specialized for nectar feeding from flowers can become co-opted during the course of evolution to enable sucking blood."

Credit: 
Chinese Academy of Sciences Headquarters

Socioeconomic background linked to survival after having a cardiac arrest in hospital

image: Graphical abstract

Image: 
European Heart Journal

Hospital in-patients from lower socioeconomic backgrounds are less likely to receive prompt cardiopulmonary resuscitation (CPR) after their hearts stop beating and less likely to survive than patients from higher socioeconomic backgrounds.

These are the findings of a new study in over 24,000 patients in Sweden, published in the European Heart Journal [1] today (Monday). It is the first European study to investigate this and the first to show that socioeconomic status (SES), rather than other factors, is important. The authors believe their findings could hold true for other European countries as well.

It is known that people with lower SES are less likely to survive a sudden cardiac arrest outside the hospital setting compared to those of higher SES but, until now, it has not been clear whether this was the case for patients already in hospital where they could expect to receive the same standard of care regardless of their backgrounds.

In the current study, Professor Jens Agerström, from Linnaeus University in Kalmar and Växjö, Sweden, and his Swedish colleagues, found that patients in hospital with higher incomes and education were significantly less likely to experience a delay in receiving CPR after a cardiac arrest, and significantly more likely to survive until discharge from hospital and for 30 days after the cardiac arrest.

Prof. Agerström said: "The good news is that for most of the cardiac arrest cases in this study, socioeconomic status didn't seem to matter. Nevertheless, there seems to be a significant number of deaths that can still be attributed to socioeconomic factors, even when we take account of things that could affect the results such as gender, age, ethnicity, other health conditions, cause of the cardiac arrest, and the specific hospital providing the treatment.

"The study investigated several outcomes but, for example, if we look at survival for 30 days after the cardiac arrest, approximately 280 people in 1000 from a low socioeconomic background will survive; however, for patients from a high socioeconomic background approximately 320 people may survive to 30 days."

The researchers also found that patients with higher SES were significantly more likely to have their heart rhythm monitored before they suffered a cardiac arrest and this was associated with less delay before CPR, a shorter duration of CPR and increased survival immediately afterwards and 30 days later. This could partially explain the differences in survival.

Prof. Agerström said: "Even when we took account of patients' other medical conditions, we found that patients with higher income and education were more likely to receive heart rhythm monitoring. In fact, we found that patients from high socioeconomic backgrounds were more likely to be monitored even if their health status was better than patients from low socioeconomic backgrounds. This suggests that there may be a bias in the way treatment is provided. Although doctors make the decision whether or not to monitor heart rhythm, we cannot rule out that patients from high socioeconomic backgrounds may request more monitoring."

The researchers write in their paper: "The finding that SES difference remain after controlling for major demographic, clinical and contextual factors suggests the presence of treatment bias/discrimination. Such bias, where patients are treated differently due to their SES, may stem from prejudiced attitudes among hospital staff."

They continue: "Reassuringly, however, most of the uncovered associations between patient SES and the studied outcomes are small, meaning that a large majority of IHCA [in-hospital cardiac arrest] patients with low SES is not subjected to disparate treatment. However, because human lives are at stake, a SES-related survival odds difference of approximately 21% (our effect size for 30-day survival) should not be ignored. This would mean that 818 of the 14,714 IHCA deaths of the lowly educated patients . . . could be attributed to education." They suggest that hospitals may want to consider enrolling their cardiac arrest teams in equality training programmes to help them be aware of their possible bias and how this could translate into discriminatory treatment.

The researchers analysed data from the Swedish National Registry of Cardiopulmonary Resuscitation for 24,217 cardiac arrests that occurred in patients aged 40 or over in Swedish hospitals between 2005 and 2018. They obtained socioeconomic data on patients from a second database and they used highest level of education and annual income as indicators of SES. They adjusted their results to take account of factors that could affect them, such as age, gender, ethnicity, other medical conditions, hospital where they were treated, heart rhythm and the cause of the cardiac arrest.

Prof. Agerström said: "The current study only examined cases where resuscitation was started because these are the cases that appear in the Swedish National Registry of CPR. It's possible that SES disparities are more pronounced when the medical staff decide whether or not to initiate CPR in the first place."

Other limitations of the study include that it can show only that the SES is associated with CPR and survival, not that SES causes fewer CPR attempts and lower survival rates among people with low SES. The researchers did not have access to smoking habits and other lifestyle factors and, because the study was conducted in Sweden, it might not be possible to generalise to other countries.

"Because it has been shown that people with low SES face prejudiced attitudes in many societies and cultures, it is possible that there are SES disparities in in-hospital cardiac arrest care and outcome in other European countries too. This, of course, rests on the assumption that prejudice plays an important role in the observed differences," said Prof. Agerström.

He said he was prompted to carry out the research because of his own experiences. "After having studied discrimination in the labour market for many years with Dr. Magnus Carlsson, one of my co-authors, we thought that a natural next step would be to look at the health care system and possible treatment discrimination, which is much less researched. My own medical visits also played a role, as I got the impression that the staff often became more thorough after they had asked me about my profession."

Credit: 
European Society of Cardiology

Study resolves the position of fleas on the tree of life

A study of more than 1,400 protein-coding genes of fleas has resolved one of the longest standing mysteries in the evolution of insects, reordering their placement in the tree of life and pinpointing who their closest relatives are.

The University of Bristol study, published in the journal Palaeoentomology, drew on the largest insect molecular dataset available. The dataset was analysed using new statistical methods, including more sophisticated algorithms, to test all historically proposed hypotheses about the placement of fleas on the insect tree of life and search for new potential relationships.

The findings overturn previously held theories about fleas, the unusual anatomy of which has meant that they eluded classification in evolutionary terms. According to the authors of the study, contrary to popular belief, fleas are technically scorpionflies, which evolved when they started feeding on the blood of vertebrates sometime between the Permian and Jurassic, between 290 and 165 million years ago.

The closest living relatives of fleas are the members of the scorpionfly family Nannochoristidae, a rare group with only seven species native to the southern hemisphere. Unlike the blood-thirsty fleas, adult nannochoristid scorpionflies lead a peaceful existence feeding on nectar.

"Of all the parasites in the animal kingdom, fleas hold a pre-eminent position. The Black Death, caused by a flea-transmitted bacterium, was the deadliest pandemic in the recorded history of mankind; it claimed the lives of possibly up to 200 million people in the 14th century," says lead author and undergraduate student Erik Tihelka from the School of Earth Sciences.

"Yet despite their medical significance, the placement of fleas on the tree of life represents one of the most persistent enigmas in the evolution of insects."

It used to be thought that all blood-feeding parasitic insects began life as either predators or by living alongside vertebrate hosts in their nests. In actual fact, blood feeding can evolve in groups that originally fed on nectar and other plant secretions.

"It seems that the elongate mouthparts that are specialized for nectar feeding from flowers can become co-opted during the course evolution to enable sucking blood," says Mattia Giacomelli, a PhD student at the University of Bristol who participated in the study.

Previous studies had suggested a connection between fleas and anatomically unusual groups of scorpionflies, but their exact relationships remained unresolved. The mystery was prolonged by the fact that flea genomes underwent rapid evolution, which makes reconstructing ancient evolutionary relationships challenging. Moreover, the nannochoristids are a quite rare and little-studied group that only occurs in New Zealand, southeastern Australia, Tasmania, and Chile, so they are easy to overlook.

"The new results suggest that we may need to revise our entomology textbooks. Fleas no longer deserve the status of a separate insect order, but should actually be classified within the scorpionflies," says Chenyang Cai, associate professor at the Nanjing Institute of Geology and Palaeontology (NIGP) and a research fellow at the University of Bristol specialising on Mesozoic insects.

"We have exceptionally preserved fossil fleas from the Jurassic and Cretaceous. In particular, some Jurassic fleas from China, about 165 million years old, are truly giant and measure up to two centimetres. They may have fed on dinosaurs, but that is exceedingly difficult to tell. What is more interesting is that these ancient fleas share important characters with modern scorpionflies."

Credit: 
University of Bristol

COVID-19: avoiding hospital caused heart disease death rise

Lower rates of hospital attendance for urgent heart problems during the initial phase of the COVID-19 pandemic may have contributed to avoidable deaths in England, finds a new study led by UCL researchers.

In the wake of the coronavirus pandemic, a marked decline* in patient visits to Emergency Departments (EDs) was observed in England and the US, including for people with heart problems.

In this study, published online in the journal Circulation cardiovascular quality and outcomes, researchers at UCL's Institute of Health Informatics estimated the effect of reduced ED visits for suspected cardiac disease on non-COVID-19 related cardiac mortality in England.

To quantify the number of excess deaths due to cardiac disease, the team used mortality counts from the Office of National Statistics (ONS) for England. To quantify the change in daily ED visits, researchers used data from the Public Health England (PHE) Emergency Department Syndromic Surveillance System (EDSSS): a network of sentinel EDs across England. To explore how the reduction in ED visits may have affected cardiac mortality, researchers implemented causal inference methodology.

Lead author Dr Michail Katsoulis (UCL Institute of Health Informatics) said: "During the initial phase of the pandemic, between March 12** and April 15, 2020, there was an estimated fewer ED visits of 2,750 per week for suspected cardiac disease; this is around a 35% decrease compared to the pre-pandemic period this year.

"Our analysis suggested that one cardiac death might have been prevented or delayed for every additional 12 ED visits for suspected cardiac conditions. We estimated that the excess cardiac mortality due to non-attendance at EDs, during the initial phase of the pandemic, may have been as high as 232 deaths per week."

Senior author Dr Tom Lumbers (UCL Institute of Health Informatics) said: "While the decline of patients accessing hospital care during the pandemic has been well documented, here we provide an estimate of the health consequences of this change in healthcare utilisation.

"The public health messaging to protect the NHS may have led to patients not attending ED out of fear or public-mindedness or difficulty accessing services due to the pandemic.

"Our results suggest that the pandemic response may have led to the undertreatment of non-COVID-19 diseases, including heart conditions, with important impacts on the excess mortality observed during this period."

Dr Lumbers added: "These results provide evidence of the stark indirect effects of the COVID-19 pandemic on mortality in England. There is a need to better understand how the pandemic response resulted in a decline in attendance to EDs with suspected cardiac disease and other serious medical conditions to inform future strategies to mitigate both the direct and indirect effects of the pandemic."

Study limitations

The research team's estimates rest upon the assumption that the COVID-19 pandemic only affects excess deaths from cardiac disease through the reduction in ED admissions, and not as a result of other factors, such as increased stress and anxiety.

Another potential limitation of this study is the possible misclassification of cardiac deaths as not related to COVID-19, since SARS-CoV-2 viral infection was excluded on clinical grounds and not through systematic viral ribonucleic acid testing.

Credit: 
University College London

Study sheds new light on how the brain distinguishes speech from noise

image: This image shows histological confirmation of recording sites. Fluoro-Gold deposited at the end of separate recordings from MNTB and MSO (dotted areas) are clearly separated and localized to target nuclei, confirming precise targeting to recording sites based on  acoustically driven responses.   

Image: 
Chao Zhang, Nichole L. Beebe, Brett R. Schofield, Michael Pecka and R. Michael Burger

For the first time, researchers have provided physiological evidence that a pervasive neuromodulation system - a group of neurons that regulate the functioning of more specialized neurons - strongly influences sound processing in an important auditory region of the brain. The neuromodulator, acetylcholine, may even help the main auditory brain circuitry distinguish speech from noise.

"While the phenomenon of these modulators' influence has been studied at the level of the neocortex, where the brain's most complex computations occur, it has rarely been studied at the more fundamental levels of the brain," says R. Michael Burger, professor of neuroscience at Lehigh University.

Burger and Lehigh Ph.D. student Chao Zhang?along with collaborators Nichole Beebe and Brett Schofield of Northeast Ohio Medical University and Michael Pecka of Ludwig-Maximilians University Munich?conducted the research. The findings have been described in an article, "Endogenous Cholinergic Signaling Modulates Sound-evoked Responses of the Medial Nucleus of the Trapezoid Body," published earlier this month in The Journal of Neuroscience. The journal's editors designated the article as "noteworthy" and it was included in "featured research" for its particular significance to the scientific community.

"This study will likely bring new attention in the field to the ways in which circuits like this, widely considered a 'simple' one, are in fact highly complex and subject to modulatory influence like higher regions of the brain," says Burger.

The team conducted electrophysiological experiments and data analysis to demonstrate that the input of the neurotransmitter acetylcholine, a pervasive neuromodulator in the brain, influences the encoding of acoustic information by the medial nucleus of the trapezoid body (MNTB), the most prominent source of inhibition to several key nuclei in the lower auditory system. MNTB neurons have previously been considered computationally simple, driven by a single large excitatory synapse and influenced by local inhibitory inputs. The team demonstrates that in addition to these inputs, acetylcholine modulation enhances neural discrimination of tones from noise stimuli, which may contribute to processing important acoustic signals such as speech. Additionally, they describe novel anatomical projections that provide acetylcholine input to the MNTB.

Burger studies the circuit of neurons that are "wired together" in order to carry out the specialized function of computing the locations from which sounds emanate in space. He describes neuromodulators as broader, less specific circuits that overlay the more highly-specialized ones.

"This modulation appears to help these neurons detect faint signals in noise," says Burger. "You can think of this modulation as akin to shifting an antenna's position to eliminate static for your favorite radio station."

"In this paper, we show that modulatory circuits have a profound effect on neurons in the sound localization circuitry, at very low foundational level of the auditory system," adds Zhang.

In addition, during the course of this study, the researchers identified for the first time a set of completely unknown connections in the brain between the modulatory centers and this important area of the auditory system.

Burger and Zhang think these findings could shed new light on the contribution of neuromodulation to fundamental computational processes in auditory brainstem circuitry, and that it also has implications for understanding how other sensory information is processed in the brain.

Credit: 
Lehigh University